Compare REED & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REED | VTGN |
|---|---|---|
| Founded | 1987 | 1998 |
| Country | United States | United States |
| Employees | 44 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.6M | 24.1M |
| IPO Year | N/A | 2014 |
| Metric | REED | VTGN |
|---|---|---|
| Price | $1.73 | $0.63 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $0.90 |
| AVG Volume (30 Days) | 31.1K | ★ 593.9K |
| Earning Date | 05-12-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ N/A | N/A |
| Revenue This Year | $18.74 | $124.49 |
| Revenue Next Year | $18.00 | $353.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.42 | $0.43 |
| 52 Week High | $5.97 | $5.14 |
| Indicator | REED | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 31.11 | 51.43 |
| Support Level | N/A | $0.54 |
| Resistance Level | $2.67 | $0.64 |
| Average True Range (ATR) | 0.35 | 0.05 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 17.21 | 48.37 |
Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.